Abstract: Idiopathic Pulmonary Fibrosis (IPF) and Tuberculosis (TB) are both complicated diseases and gradually increasing their incidence rates worldwide. Some population-based studies reported that ...

University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn ...

ETHealthworld.com brings latest bdr pharma news, views and updates from all top sources for the Indian Health industry.

Background: Idiopathic Pulmonary fibrosis (IPF) is a complex and deadly disease with limited treatment options. A better understanding of the cellular and molecular mechanisms involved in IPF could ...

Novel Coronavirus (COVID-19) The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) continues to reshape the globe. Stay current with the latest updates essential for healthcare ...

Nerandomilast may represent a meaningful addition to the treatment arsenal, offering patients and clinicians a new option for pulmonary fibrosis. A new systematic review and meta-analysis suggests ...

For many people, the COVID-19 pandemic feels like a distant memory. In reality, the SARS‑CoV‑2 coronavirus is still spreading widely across the globe and continues to evolve into new variants.

Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Retroperitoneal fibrosis is ...

A COVID-19 variant that has remained "underground" for years is catching the attention of health officials in the United States and abroad. The Centers for Disease Control and Prevention (CDC) said in ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A new COVID variant known as BA.3.2 has been detected across 25 U.S. states and may make immunity from vaccines or past ...